Roche pulls out of vaccine alliance with Transgene
February 23, 2011Research and Development HPV, HPV vaccine, Roche, TG4001, Transgene, cervical cancer, cervical lesions, human papilloma virus, vaccines
Roche has terminated its license agreement with Transgene for its HPV therapeutic vaccine TG4001. The vaccine is currently being tested …
Online international research register launched
February 23, 2011Research and Development CRD, Centre for Reviews and Dissemination, Department of Health, NIHR, National Institute for Health Research, Prospero, clinical research, health research register
The UK government has backed the creation of a free, international online register to improve the transparency of health research. …
No magic bullet, but a growing arsenal against lung cancer
February 23, 2011Research and Development ASA404, Cancer, Iressa, NSCLC, Tarceva, afatinib, crizotinib, figitumumab, lung cancer, non small cell lung cancer, non-small cell lung cancer
A man in his 70s is waiting for his appointment with the oncologist after being referred there by his family …
J&J hepatitis C drug begins phase III trials
February 23, 2011Research and Development J&J, JJ, Johnson and Johnson, TMC435, Tibotec, hepatitis, hepatitis C
Johnson & Johnson has begun late stage trials of hepatitis C drug TMC435 as a first line treatment for the …
NICE yes for Votrient, no to Avastin
February 23, 2011Sales and Marketing Cancer, GSK, GlaxoSmithKline, Kidney cancer, NICE, Roche, avastin, bevacizumab, breast cancer
NICE has recommended GlaxoSmithKline’s kidney cancer drug Votrient on the same day it gave a final negative decision to Roche’s …
Commissioning Board to spearhead NHS reforms
February 23, 2011GP consortia, Health and Social Care Bill, NHS, NHS Commissioning Board, NHS reforms, PCT clusters, PCTs, SHAs, Sir David Nicholson, pathfinder consortia
NHS chief executive Sir David Nicholson says the new NHS Commissioning Board will be the driving force behind the health …
Kieran Murphy to head up life sciences for GE Healthcare
February 23, 2011Research and Development, Sales and Marketing GE Healthcare, Kieran Murphy, appointment, research and development, sales and marketing
GE Healthcare has promoted Kieran Murphy to succeed its current Life Sciences president and chief executive Peter Ehrenheim. Kieran, who …
Contract research news in brief
February 23, 2011Research and Development Bioanalytical Systems, Evotec, Iris Pharma, Kancera, Kinaxo Biotechnologies, NSF International, Pharmalytica Services, iNovacia
Acquisitions by Evotec, Kancera and NSF International head our latest CRO news round-up, along with updates from BASi and Iris …
Sanofi partners on dengue vaccine awareness
February 22, 2011Medical Communications, Research and Development Dengue Vaccine Institute, Dengue fever, International Vaccine Institute, Sanofi Pasteur, Sanofi-Aventis, disease awareness, vaccines
Sanofi-Aventis has teamed up with the International Vaccine Institute to raise awareness about dengue fever and its vaccine for the …
Scottish biotech ProStrakan sold for £292m
February 22, 2011Research and Development KHK, Kyowa Hakko Kirin, ProStrakan, Scottish biotech, biotech
Scottish biotech ProStrakan is to be bought by Japanese manufacturer Kyowa Hakko Kirin for £292 million. The companies agreed the …
Pharma must rethink manufacturing, says PwC
February 22, 2011Manufacturing and Production pharma manufacturing, pricewaterhousecoopers, pwC
The pharmaceutical industry needs to undertake a radical overhaul in its approach to manufacturing which at present is “inefficient, under-utilised …
AstraZeneca plans $150m plant in Russia
February 22, 2011Manufacturing and Production, Sales and Marketing AstraZeneca, Russia, emerging pharma markets, pharma manufacturing
AstraZeneca has become the latest drugmaker to announce the construction of a manufacturing facility in Russia to help sidestep possible …
Quality problems lead to short-term layoffs at Baxter Ireland
February 22, 2011Manufacturing and Production Dianeal, Extraneal, Ireland, Nutrineal, baxter, job cuts, manufacturing compliance, peritoneal dialysis
A contaminated production line at a facility in Ireland operated by Baxter Healthcare has resulted in 150 staff being laid …
James Christie joins Oxford BioMedica as manufacturing head
February 22, 2011Manufacturing and Production James Christie, Oxford BioMedica, appointment, manufacturing and production
UK gene therapy company Oxford BioMedica has appointed James Christie as its first head of manufacturing. It following the firm’s …
SHL to speak at Drug Delivery System Development and Lifecycle Management Requirements for Biologic Pharmaceuticals: Trends and Best Practices
February 22, 2011Manufacturing and Production auto injector, autoinjector, drug delivery, shl group
The 2011 DCAT Biologics Forum will focus on trends and best practices for subcutaneous biologic drug delivery systems featuring presentations …
Europe votes in new anti-counterfeit law
February 21, 2011Manufacturing and Production EFPIA, counterfeits, supply chain
The European Parliament has voted in favour of the Falsified Medicines Directive to help stop the flow of counterfeit medicines …
Four steps to turn around a flagging pharma brand
February 21, 2011Sales and Marketing MSI, branding, brands, marketing
The glamorous end of pharma marketing is undoubtedly around the launch of a new product. Everyone is excited and optimistic, …
Idea Pharma boosts UK and US teams
February 21, 2011Sales and Marketing IDEA Pharma, Jeff Frick, Michael Morgan-Curran, appointment, sales and marketing
Idea Pharma has made new appointments to its UK- and US-based teams
Astellas to commercialise new kidney cancer drug in Europe
February 21, 2011Sales and Marketing Astellas, Aveo Pharmaceuticals, Cancer, Kidney cancer, rcc, renal cell carcinoma, tivozanib
Astellas and Aveo Pharmaceuticals are to commercialise Aveo’s investigational kidney cancer drug tivozanib in Europe and the US. Aveo is …
J&J hit by another string of product recalls
February 21, 2011Manufacturing and Production J&J, JJ, Johnson & Johnson, Simponi, golimumab, manufacturing compliance, pharma recalls
There seems to be no end to the quality troubles plaguing Johnson & Johnson, with several more recalls to report, …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
